Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice

被引：45
|
作者：
Zhang, Mengling [1 ,2 ,3 ]
Sun, Jin [1 ]
Li, Min [1 ]
Jin, Xia [3 ]
机构：
[1] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
[3] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2020年 / 18卷
基金：
美国国家科学基金会; 国家重点研发计划;
关键词：
TETRAVALENT DENGUE VACCINE; NONSTRUCTURAL PROTEIN NS1; DNA VACCINE; VIRUS; EFFICACY; IMMUNITY; ENHANCEMENT; ANTIBODIES; INFLUENZA; RESPONSES;
D O I：
10.1016/j.omtm.2020.07.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Dengue virus (DENV) infection is a major global public health concern, and there is no effective vaccine for it. In this study, we describe the design and characterization of three nucleotide-modified mRNA vaccines (prME-mRNA, E80-mRNA, and NS1-mRNA) for DENV-2. Our results showed that vaccination with E80-mRNA alone or a combination of E80-mRNA and NS1-mRNA can induce high levels of neutralizing antibodies and antigen-specific T cell responses; furthermore, these vaccines confer complete protection against DENV-2 challenge in immunocompetent mice. These data provide foundations for further development of a tetravalent DENV vaccine based on nucleotide-modified mRNA.
引用
收藏
页码：702 / 712
页数：11
相关论文
共 50 条
  • [1] A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
    Lihong He
    Wenqiang Sun
    Limin Yang
    Wenjun Liu
    Jing Li
    Virologica Sinica, 2022, 37 (05) : 746 - 757
  • [2] A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
    Lihong He
    Wenqiang Sun
    Limin Yang
    Wenjun Liu
    Jing Li
    Virologica Sinica, 2022, (05) : 746 - 757
  • [3] A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
    He, Lihong
    Sun, Wenqiang
    Yang, Limin
    Liu, Wenjun
    Li, Jing
    VIROLOGICA SINICA, 2022, 37 (05) : 746 - 757
  • [4] Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
    Granados-Riveron, Javier T.
    Aquino-Jarquin, Guillermo
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [5] A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection
    Alameh, Mohamad-Gabriel
    Semon, Alexa
    Bayard, Nile U.
    Pan, Yi-Gen
    Dwivedi, Garima
    Knox, James
    Glover, Rochelle C.
    Rangel, Paula C.
    Tanes, Ceylan
    Bittinger, Kyle
    She, Qianxuan
    Hu, Haitao
    Bonam, Srinivasa Reddy
    Maslanka, Jeffrey R.
    Planet, Paul J.
    Moustafa, Ahmed M.
    Davis, Benjamin
    Chevrier, Anik
    Beattie, Mitchell
    Ni, Houping
    Blizard, Gabrielle
    Furth, Emma E.
    Mach, Robert H.
    Lavertu, Marc
    Sellmyer, Mark A.
    Tam, Ying
    Abt, Michael C.
    Weissman, Drew
    Zackular, Joseph P.
    SCIENCE, 2024, 386 (6717) : 69 - 75
  • [6] mRNA-LNP vaccines combined with tPA signal sequence elicit strong protective immunity against Klebsiella pneumoniae
    Huang, Ting
    Che, Siyou
    Lv, Zheng
    Hao, Danrui
    Wang, Runyu
    Yi, Qinxuan
    Mei, Ling
    Yuan, Yang
    Zou, Hang
    Guo, Yidong
    Wang, Xinrong
    Chu, Yiwen
    Zhao, Kelei
    MSPHERE, 2025, 10 (01)
  • [7] Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
    Vaca, Gabriela Baldeon
    Meyer, Michelle
    Cadete, Ana
    Hsiao, Chiaowen Joyce
    Golding, Anne
    Jeon, Albert
    Jacquinet, Eric
    Azcue, Emily
    Guan, Chenxia Monica
    Sanchez-Felix, Xavier
    Pietzsch, Colette A.
    Mire, Chad E.
    Hyde, Matthew A.
    Comeaux, Margaret E.
    Williams, Julie M.
    Sung, Jean C.
    Carfi, Andrea
    Edwards, Darin K.
    Bukreyev, Alexander
    Bahl, Kapil
    SCIENCE ADVANCES, 2023, 9 (38)
  • [8] Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
    England, Ross N.
    Drapeau, Elizabeth M.
    Alameh, Mohamad-Gabriel
    Hosseinzadeh, Reihaneh
    Weissman, Drew
    Hensley, Scott E.
    NPJ VACCINES, 2024, 9 (01)
  • [9] Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
    Abushahba, Mostafa F.
    Dadelahi, Alexis S.
    Lemoine, Emily L.
    Skyberg, Jerod A.
    Vyas, Swati
    Dhoble, Sagar
    Ghodake, Vinod
    Patravale, Vandana B.
    Adamovicz, Jeffrey J.
    VACCINES, 2023, 11 (03)
  • [10] Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
    da Silva, Jamile Ramos
    Rodrigues, Karine Bitencourt
    Pelegrin, Guilherme Formoso
    Sales, Natiely Silva
    Muramatsu, Hiromi
    Silva, Mariangela de Oliveira
    Porchia, Bruna F. M. M.
    Moreno, Ana Carolina Ramos
    Aps, Luana Raposo M. M.
    Venceslau-Carvalho, Alexia Adrianne
    Tombacz, Istvan
    Fotoran, Wesley Luzetti
    Kariko, Katalin
    Lin, Paulo J. C.
    Tam, Ying K.
    Diniz, Mariana de Oliveira
    Pardi, Norbert
    Ferreira, Luis Carlos de Souza
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (686)
12345